Cytori Therapeutics has received the patent protecting its Celution® System applications for generation of adipose tissue-derived stem and regenerative cell-enhanced fat grafts that may be used in a variety of cosmetic surgery procedures, such as breast reconstruction, facial applications etc. The patent strengthens the competitive position of Celution System in the cosmetic surgery market. Cytori also seeks to protect other applications of the Celution System. Additional patents for the use of Celution System in cardiovascular and orthopedic proceduress have been filed too.

Mentor Corporation has launched an online educational resource for women considering breast augmentation and other cosmetic procedures. The site, www.LoveYourLook.com, is aimed at providing the most comprehensive information for women researching cosmetic surgery. This would help women make informed decisions and contact qualified physicians in their area. The site includes information on Mentor’s MemoryGel™ silicone implants.

Two new rule changes in Canada approved by College of Physicians and Surgeons of Ontario (CPSO) will stop a General Practitioner from advertising as a cosmetic surgeon so that people may be able to undergo cosmetic surgery with a trained professional. The practice of family doctors performing liposuctions and breast enlargements without proper training has been increasing in Canada.

 Photo by Shazron

In late January, a consumer group called Public Citizen filed a petition with the FDA requesting labeling alterations for botulinum toxins (Botox(R)) or Myobloc(R)) marketed in the U.S. The American Society for Aesthetic Plastic Surgery (ASAPS), which is the sole plastic surgery organization devoted completely to the advancement of cosmetic surgery, said that “the safety references in the petition are already satisfactorily addressed in the manufacturer labeling with detailed information and guidance, including approved indications, contraindications, warnings, drug interactions, precautions, and reported adverse event information.”

The ASAPS added that the product is “safe and efficacious,” while recommending its continued use as indicated.